The group�s principle activity is to commercializing novel and proprietary ADMET products for drug discovery and development customers. The group also provides better knowledge to researchers regarding drug candidate compounds. The group�s products include B-clear(R), Accurate(TM), and Accupro(TM). The group operates from United States.
